- Home
- SLNO vs DBD Comparison
SLNO vs DBD Comparison
Compare SLNO & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- DBD
- Stock Information
- Founded
- SLNO 1999
- DBD 1859
- Country
- SLNO United States
- DBD United States
- Employees
- SLNO N/A
- DBD N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DBD EDP Services
- Sector
- SLNO Health Care
- DBD Technology
- Exchange
- SLNO Nasdaq
- DBD Nasdaq
- Market Cap
- SLNO 1.9B
- DBD 1.6B
- IPO Year
- SLNO 2014
- DBD N/A
- Fundamental
- Price
- SLNO $49.17
- DBD $45.91
- Analyst Decision
- SLNO Strong Buy
- DBD Strong Buy
- Analyst Count
- SLNO 6
- DBD 2
- Target Price
- SLNO $74.83
- DBD $57.50
- AVG Volume (30 Days)
- SLNO 567.7K
- DBD 103.8K
- Earning Date
- SLNO 03-05-2025
- DBD 02-12-2025
- Dividend Yield
- SLNO N/A
- DBD N/A
- EPS Growth
- SLNO N/A
- DBD N/A
- EPS
- SLNO N/A
- DBD 0.00
- Revenue
- SLNO N/A
- DBD $3,799,000,000.00
- Revenue This Year
- SLNO N/A
- DBD $0.73
- Revenue Next Year
- SLNO N/A
- DBD $1.58
- P/E Ratio
- SLNO N/A
- DBD $14,857.61
- Revenue Growth
- SLNO N/A
- DBD 2.88
- 52 Week Low
- SLNO $36.61
- DBD $30.01
- 52 Week High
- SLNO $60.92
- DBD $51.81
- Technical
- Relative Strength Index (RSI)
- SLNO 56.57
- DBD 61.38
- Support Level
- SLNO $45.44
- DBD $39.90
- Resistance Level
- SLNO $49.03
- DBD $43.46
- Average True Range (ATR)
- SLNO 2.36
- DBD 1.04
- MACD
- SLNO 0.66
- DBD 0.38
- Stochastic Oscillator
- SLNO 98.40
- DBD 95.85
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.